Toolkit/opto-iTrkA

opto-iTrkA

Construct Pattern·Research·Since 2019

Also known as: iLID opto-iTrkA

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

opto-iTrkA is an iLID-based light-activated TrkA construct engineered to control TrkA receptor signaling with blue light. The intracellular TrkA module is cytosolic, monomeric, and inactive in the dark, and activation requires light-driven recruitment in the presence of tdnano to reproduce downstream ERK and Akt signaling.

Usefulness & Problems

Why this is useful

This construct enables optical control of TrkA pathway activation with conditional dependence on a binding partner, tdnano. It is reported to be compatible with multi-day and population-level activation of TrkA in PC12 cells, supporting experiments that require repeated or extended stimulation.

Problem solved

opto-iTrkA addresses the problem of activating TrkA signaling with light rather than constitutive or ligand-based stimulation. The reported design also constrains signaling output by requiring tdnano for downstream ERK and Akt activation.

Problem links

Need conditional control of signaling activity

Derived

opto-iTrkA is an iLID-based light-activated TrkA construct engineered to control TrkA receptor signaling with blue light. The intracellular TrkA module is cytosolic, monomeric, and inactive in the dark, and activation requires light-driven recruitment in the presence of tdnano to reproduce downstream ERK and Akt signaling.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A reusable architecture pattern for arranging parts into an engineered system.

Techniques

No technique tags yet.

Target processes

signaling

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: regulatorswitch architecture: recruitment

The construct is described as iLID-based and requires blue light for activation. Reported activity depends on the presence of tdnano, and compatibility was specifically noted for PC12 cells in multi-day and population-level activation experiments.

The supplied evidence comes from a single 2019 source and provides limited quantitative performance details. No independent replication, kinetic parameters, dynamic range, or validation outside PC12 cells are provided in the evidence set.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 2activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 3activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 4activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 5activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 6activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 7activitysupports2019Source 1needs review

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.
Claim 8compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 9compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 10compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 11compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 12compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 13compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 14compatibilitysupports2019Source 1needs review

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.
Claim 15mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 16mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 17mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 18mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 19mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 20mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 21mechanismsupports2019Source 1needs review

In the absence of light, iLID-RTK is cytosolic, monomeric, and inactive.

In the absence of light, the iLID-RTK is cytosolic, monomeric and inactive.
Claim 22mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 23mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 24mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 25mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 26mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 27mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 28mechanismsupports2019Source 1needs review

Under blue light, the iLID plus tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.

Under blue light, the iLID + tdnano system recruits two copies of iLID-RTK to tdnano, dimerizing and activating the RTK.
Claim 29targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 30targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 31targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 32targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 33targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 34targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination
Claim 35targetingsupports2019Source 1needs review

Genetic targeting of tdnano enables RTK activation at a specific subcellular location even with whole-cell illumination.

By leveraging genetic targeting of tdnano, we achieve RTK activation at a specific subcellular location even with whole-cell illumination

Approval Evidence

1 source2 linked approval claimsfirst-pass slug opto-itrka
We demonstrate that iLID opto-iTrkA

Source:

activitysupports

opto-iTrkA and opto-iTrkB reproduce downstream ERK and Akt signaling only in the presence of tdnano.

We demonstrate that iLID opto-iTrkA and opto-iTrkB are capable of reproducing downstream ERK and Akt signaling only in the presence of tdnano.

Source:

compatibilitysupports

opto-iTrkA is compatible with multi-day and population-level activation of TrkA in PC12 cells.

We further show with our opto-iTrkA that the system is compatible with multi-day and population-level activation of TrkA in PC12 cells.

Source:

Comparisons

Source-backed strengths

Source claims indicate that opto-iTrkA reproduces downstream ERK and Akt signaling only in the presence of tdnano, consistent with partner-dependent activation. It is also reported to support multi-day and population-level TrkA activation in PC12 cells, suggesting utility beyond acute single-cell stimulation.

opto-iTrkA and kinase translocation reporters address a similar problem space because they share signaling.

Shared frame: same top-level item type; shared target processes: signaling

opto-iTrkA and novel fluorescent biosensor for mitochondrial outer membrane rupture address a similar problem space because they share signaling.

Shared frame: same top-level item type; shared target processes: signaling

Compared with opto-iTrkB

opto-iTrkA and opto-iTrkB address a similar problem space because they share signaling.

Shared frame: same top-level item type; shared target processes: signaling; shared mechanisms: induced dimerization, light-induced recruitment, receptor tyrosine kinase activation

Ranked Citations

  1. 1.

    Extracted from this source document.